Home
Conditions
Hematopoietic and Lymphoid Cell Neoplasm

Clinical trial condition

Hematopoietic and Lymphoid Cell Neoplasm

Explore clinical trials studying Hematopoietic and Lymphoid Cell Neoplasm. Study availability and eligibility vary by location and protocol.

160 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hematopoietic and Lymphoid Cell Neoplasm trial results

Active, not recruiting

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

NCT04177004

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

NCT03399773

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Anemia, +29 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, not recruiting

Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

NCT04439201

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematologic Diseases, +13 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

NCT04560673

Conditions: Chemotherapy-induced Peripheral Neuropathy, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: Harris Health System (LBJ) Houston, Texas, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

NCT02515383

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

NCT02862275

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +9 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Moffitt Cancer Center-International Plaza Tampa, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory University Hospital Midtown Atlanta, Georgia, United States

View Trial Details

Active, not recruiting

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain

NCT04296305

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)

NCT04439292

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)

NCT04439149

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)

NCT04439188

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm trial results

Related conditions